Abstract
The United States is currently facing an unprecedented shortage of cancer drugs. While experts do not see an end in sight, more attention is being given to the issue by media and lawmakers, prompting think tanks, members of congress, and the Biden administration to determine solutions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
